Maravai LifeSciences Holdings, Inc.
MRVI
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-basedā¦ read more
Healthcare
Biotechnology
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.53
Price-2.97%
-$0.20
1Y
Price
Market Cap
$1.804b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-10.1%
EBITDA Margin-24.1%
Net Profit Margin+7.0%
Free Cash Flow Margin-10.1%
EBITDA Margin-24.1%
Net Profit Margin+7.0%
Free Cash Flow MarginRevenue
$208.775m
+12.4%
1y CAGR-8.7%
3y CAGR-23.4%
5y CAGREarnings
-$77.386m
+40.8%
1y CAGR+9.6%
3y CAGR-31.3%
5y CAGREPS
-$0.54
+40.7%
1y CAGR+12.4%
3y CAGR-29.1%
5y CAGRBook Value
$355.588m
$603.746m
Assets$248.158m
Liabilities$176.696m
DebtDebt to Assets
29.3%
-3.1x
Debt to EBITDAFree Cash Flow
-$35.108m
+50.4%
1y CAGR-101.6%
3y CAGR-98.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company